Q3 EPS Estimates for Xeris Biopharma Cut by Leerink Partnrs
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) – Stock analysts at Leerink Partnrs lowered their Q3 2025 earnings estimates for Xeris Biopharma in a research report issued on Wednesday, June 4th. Leerink Partnrs analyst R. Ruiz now forecasts that the company will post earnings of $0.02 per share for the quarter, down from their […]
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) – Stock analysts at Leerink Partnrs lowered their Q3 2025 earnings estimates for Xeris Biopharma in a research report issued on Wednesday, June 4th. Leerink Partnrs analyst R. Ruiz now forecasts that the company will post earnings of $0.02 per share for the quarter, down from their […]
